Publications by authors named "Amy L Heaps"

Claim this Profile
A
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa.
Urvi M Parikh, Lauren D Kudrick, Lisa Levy, Everline Bosek, Bhavna H Chohan, Amy L Heaps

J Int AIDS Soc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Virologic Success on Antiretroviral Therapy Among Individuals With Breakthrough HIV Acquisition on Long-Acting Cabotegravir Pre-exposure Prophylaxis.
Urvi M Parikh, Monica Gandhi, Jessica Altamirano, Hussein Safa, Aniruddha Hazra, Amy L Heaps

Open Forum Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care.
Catherine A Koss, Monica Gandhi, Elias K Halvas, Hideaki Okochi, Carolyn Chu, Amy L Heaps

Open Forum Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment.
Urvi M Parikh, Amy L Heaps, Daniela Moisi, Kelley C Gordon, John W Mellors

Pathog Immun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response.
Marc-Kendy Paul, Manish C Choudhary, Amy L Heaps, Rinki Deo, Daniela Moisi

Pathog Immun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial.
Urvi M Parikh, Kerri J Penrose, Amy L Heaps, Rahil Sethi, B Jay Goetz

J Acquir Immune Defic Syndr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer.
Amy L Heaps, Michele D Sobolewski, Jana L Jacobs, Kelley C Gordon, Ghady Haidar

J Virol Methods· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy.
Jana L Jacobs, Ghady Haidar, Asma Naqvi, Kevin D McCormick, Michele Sobolewski, Amy L Heaps

Open Forum Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial.
Urvi M Parikh, Kerri J Penrose, Amy L Heaps, Elias K Halvas, B Jay Goetz

J Int AIDS Soc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring.
Sharon A Riddler, Jennifer E Balkus, Urvi M Parikh, John W Mellors, Carolyne Akello, Amy L Heaps

Clin Infect Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis